Skip to content
Search

Latest Stories

Hull Pharmacists’ Association donates their remaining financial assets to Pharmacist Support

Hull Pharmacists’ Association (HPA) has made a donation to Pharmacist Support in order to show their support and give back to the profession after many years of supporting their local pharmacy community.  

Andrew Hersom, President & Past Secretary, and Elizabeth Lyle, Treasurer of the association, said: “After many years of proudly championing our local pharmacy community, we’re pleased to be able to continue the legacy of Hull Pharmacists’ Association through donating our remaining financial assets to our profession’s charity. 


Our members were keen for the money to be used to benefit fellow pharmacists and their families as we all know people who have had mental health and physical problems during their professional lives. We believe, through the great work of Pharmacist Support, the donation will really help to make a difference.” 

The Association was founded in 1868 as a result of the 1868 Pharmacy Act which required pharmacists to register with the (Royal) Pharmaceutical Society of Great Britain (RPSGB) based in London. At that time, pharmacists in Hull and the East Riding felt they still needed to oversee local pharmaceutical matters themselves, and therefore set up the association. 

Since then, the HPA has focused its efforts on connecting the local pharmacy community through monthly educational and professional meetings, social events, research grants and political lobbying.  

Sadly, with the ever-changing landscape in pharmacy, not helped by the covid-19 pandemic, the committee has consulted members who have reluctantly decided the time has come to wrap up the association. Due to its long history, their records, President’s chain and bell mortar will have a home at the Treasure House Museum in the East Riding, and members kindly put a motion forward to donate their remaining financial assets to Pharmacist Support.  

Speaking of the donation, Pharmacist Support’s Chief Executive, Danielle Hunt said: “We are incredibly grateful to Hull Pharmacists’ Association for donating their remaining financial assets to the charity. The association has had a very positive impact on the profession over the years, and this generous donation will help the charity to continue to provide support to pharmacists whilst continuing to adapt to their changing needs.”  

Pharmacist Support charity relies on individual and corporate donations to ensure pharmacy students, trainees and pharmacists have access to free, independent and confidential support. 

Like many charities, Pharmacist Support has experienced fundraising challenges due to the pandemic and ongoing cost of living crisis. 

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less